Evidence map›Paper›PMID 27035636›Full record

ArticlePLoS biology2016

Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.

Sathish K Murali, Olena Andrukhova, Erica L Clinkenbeard, Kenneth E White, Reinhold G Erben

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Case Report: Deep intronicFrontiers in endocrinology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. The Diagnosis and Therapy of XLH.Calcified tissue international · 2025
    Review
  18. Article
  19. Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sathish K MuraliDepartment of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria.
Olena AndrukhovaDepartment of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria.
Erica L ClinkenbeardDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Kenneth E WhiteDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Reinhold G ErbenDepartment of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria.
University of Veterinary Medicine Vienna · ATIndiana University – Purdue University Indianapolis · US

Funding

FGF-23 REGULATION OF PHOSPHATE HOMEOSTASISR01DK063934 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WHITE, KENNETH E · 2003 to 2015
$3.8M
Control of FGF23 Bioactivity via Circulating alpha-KlothoR01DK095784 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI WHITE, KENNETH E · 2013 to 2017
$1.7M
Role of iron and hypoxia sensing in FGF23-dependent metabolic bone diseaseF32AR065389 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI CLINKENBEARD, ERICA L · 2014 to 2016
$183k
Austrian Science Fund FWF P 24186NIAMS NIH HHS F32 AR065389NIAMS NIH HHS F32-AR065389NIDDK NIH HHS R01 DK063934NIDDK NIH HHS R01-DK063934NIDDK NIH HHS R01 DK095784NIDDK NIH HHS R01-DK95784
6 · The paper itself

Abstract

X-linked hypophosphatemia (XLH) is the most frequent form of inherited rickets in humans caused by mutations in the phosphate-regulating gene with homologies to endopeptidases on the X-chromosome (PHEX). Hyp mice, a murine homologue of XLH, are characterized by hypophosphatemia, inappropriately low serum vitamin D levels, increased serum fibroblast growth factor-23 (Fgf23), and osteomalacia. Although Fgf23 is known to be responsible for hypophosphatemia and reduced vitamin D hormone levels in Hyp mice, its putative role as an auto-/paracrine osteomalacia-causing factor has not been explored. We recently reported that Fgf23 is a suppressor of tissue nonspecific alkaline phosphatase (Tnap) transcription via FGF receptor-3 (FGFR3) signaling, leading to inhibition of mineralization through accumulation of the TNAP substrate pyrophosphate. Here, we report that the pyrophosphate concentration is increased in Hyp bones, and that Tnap expression is decreased in Hyp-derived osteocyte-like cells but not in Hyp-derived osteoblasts ex vivo and in vitro. In situ mRNA expression profiling in bone cryosections revealed a ~70-fold up-regulation of Fgfr3 mRNA in osteocytes versus osteoblasts of Hyp mice. In addition, we show that blocking of increased Fgf23-FGFR3 signaling with anti-Fgf23 antibodies or an FGFR3 inhibitor partially restored the suppression of Tnap expression, phosphate production, and mineralization, and decreased pyrophosphate concentration in Hyp-derived osteocyte-like cells in vitro. In vivo, bone-specific deletion of Fgf23 in Hyp mice rescued the suppressed TNAP activity in osteocytes of Hyp mice. Moreover, treatment of wild-type osteoblasts or mice with recombinant FGF23 suppressed Tnap mRNA expression and increased pyrophosphate concentrations in the culture medium and in bone, respectively. In conclusion, we found that the cell autonomous increase in Fgf23 secretion in Hyp osteocytes drives the accumulation of pyrophosphate through auto-/paracrine suppression of TNAP. Hence, we have identified a novel mechanism contributing to the mineralization defect in Hyp mice.

Indexed as

Calcification, PhysiologicAlkaline PhosphataseAnimalsBone and BonesDiphosphatesFamilial Hypophosphatemic RicketsFibroblast Growth Factor-23Fibroblast Growth FactorsMiceOsteocytesReceptor, Fibroblast Growth Factor, Type 3RNA, MessengerVitamin D DeficiencyAlkaline PhosphataseALPL protein, mouseDiphosphatesFGF23 protein, humanFgf23 protein, mouseFgfr3 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsReceptor, Fibroblast Growth Factor, Type 3RNA, Messenger

Identifiers

PMID27035636
PMCPMC4818020
OpenAlexW2325488219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.